Close Menu

NEW YORK (GenomeWeb) – Enpicom and Cytura Therapeutics have partnered to develop a diagnostic assay for early cancer detection, the Netherlands-based companies announced on Wednesday.

Enpicom develops biomedical software including its recently launched ImmunoGenomiX platform for immune sequencing data analysis, while Cytura is developing cancer drugs targeting genomic instability.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Jun
04
Sponsored by
Ovation

This webinar will discuss the current status of COVID-19 testing, treatment and other aspects of the current pandemic as they relate to getting this outbreak under control.  

Jul
15
Sponsored by
LGC SeraCare Life Sciences

Cancer immunotherapy is an exciting new advance for the successful treatment of many forms of metastatic cancer.